138 related articles for article (PubMed ID: 11155023)
1. [Pharmaceutical comparability of different therapeutic Echinacea preperations].
Osowski S; Rostock M; Bartsch HH; Massing U
Forsch Komplementarmed Klass Naturheilkd; 2000 Dec; 7(6):294-300. PubMed ID: 11155023
[TBL] [Abstract][Full Text] [Related]
2. Absorption of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides after oral application of Echinacea purpurea tincture.
Dietz B; Heilmann J; Bauer R
Planta Med; 2001 Dec; 67(9):863-4. PubMed ID: 11745026
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system.
Woelkart K; Marth E; Suter A; Schoop R; Raggam RB; Koidl C; Kleinhappl B; Bauer R
Int J Clin Pharmacol Ther; 2006 Sep; 44(9):401-8. PubMed ID: 16995328
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Variation in Alkamides and Cichoric Acid in Roots and Aboveground Parts of Echinacea purpurea (L.) Moench.
Qu L; Chen Y; Wang X; Scalzo R; Davis JM
HortScience; 2005 Aug; 40(5):1239-1242. PubMed ID: 16429598
[TBL] [Abstract][Full Text] [Related]
5. [Echinacea drugs--effects and active ingredients].
Bauer R
Z Arztl Fortbild (Jena); 1996 Apr; 90(2):111-5. PubMed ID: 8686333
[TBL] [Abstract][Full Text] [Related]
6. Echinacea: anatomy, phytochemical pattern, and germination of the achene.
Schulthess BH; Giger E; Baumann TW
Planta Med; 1991 Aug; 57(4):384-8. PubMed ID: 1775583
[TBL] [Abstract][Full Text] [Related]
7. Comparison of chemical components and antioxidants capacity of different Echinacea species.
Sloley BD; Urichuk LJ; Tywin C; Coutts RT; Pang PK; Shan JJ
J Pharm Pharmacol; 2001 Jun; 53(6):849-57. PubMed ID: 11428661
[TBL] [Abstract][Full Text] [Related]
8. Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants.
Hou CC; Chen CH; Yang NS; Chen YP; Lo CP; Wang SY; Tien YJ; Tsai PW; Shyur LF
J Nutr Biochem; 2010 Nov; 21(11):1045-59. PubMed ID: 20005088
[TBL] [Abstract][Full Text] [Related]
9. Absolute/relative bioavailability and metabolism of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (tetraenes) after intravenous and oral single doses to rats.
Ardjomand-Woelkart K; Kollroser M; Magnes C; Sinner F; Frye RF; Derendorf H; Bauer R; Butterweck V
Planta Med; 2011 Nov; 77(16):1794-9. PubMed ID: 21604240
[TBL] [Abstract][Full Text] [Related]
10. Purification of alkylamides from Echinacea angustifolia (DC.) Hell. Roots by high-speed countercurrent chromatography.
Lopes-Lutz D; Mudge E; Ippolito R; Brown P; Schieber A
J Agric Food Chem; 2011 Jan; 59(2):491-4. PubMed ID: 21190380
[TBL] [Abstract][Full Text] [Related]
11. The bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MS.
Goey AK; Rosing H; Meijerman I; Sparidans RW; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():151-6. PubMed ID: 22770780
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous analysis of caffeic acid derivatives and alkamides in roots and extracts of Echinacea purpurea by high-performance liquid chromatography-photodiode array detection-electrospray mass spectrometry.
Luo XB; Chen B; Yao SZ; Zeng JG
J Chromatogr A; 2003 Jan; 986(1):73-81. PubMed ID: 12585324
[TBL] [Abstract][Full Text] [Related]
13. Effect of temperature on stability of marker constituents in Echinacea purpurea root formulations.
Livesey J; Awang DV; Arnason JT; Letchamo W; Barrett M; Pennyroyal G
Phytomedicine; 1999 Nov; 6(5):347-9. PubMed ID: 11962542
[TBL] [Abstract][Full Text] [Related]
14. Macrophage activating effects of new alkamides from the roots of Echinacea species.
Chen Y; Fu T; Tao T; Yang J; Chang Y; Wang M; Kim L; Qu L; Cassady J; Scalzo R; Wang X
J Nat Prod; 2005 May; 68(5):773-6. PubMed ID: 15921428
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and immunomodulatory effects of phytotherapeutic lozenges (bonbons) with Echinacea purpurea extract.
Guiotto P; Woelkart K; Grabnar I; Voinovich D; Perissutti B; Invernizzi S; Granzotto M; Bauer R
Phytomedicine; 2008 Aug; 15(8):547-54. PubMed ID: 18583121
[TBL] [Abstract][Full Text] [Related]
16. Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE₂ from RAW 264.7 macrophage-like cells.
Cech NB; Kandhi V; Davis JM; Hamilton A; Eads D; Laster SM
Int Immunopharmacol; 2010 Oct; 10(10):1268-78. PubMed ID: 20674883
[TBL] [Abstract][Full Text] [Related]
17. Light-mediated antifungal activity of Echinacea extracts.
Binns SE; Purgina B; Bergeron C; Smith ML; Ball L; Baum BR; Arnason JT
Planta Med; 2000 Apr; 66(3):241-4. PubMed ID: 10821050
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
19. Chromatographic methods for metabolite profiling of virus- and phytoplasma-infected plants of Echinacea purpurea.
Pellati F; Epifano F; Contaldo N; Orlandini G; Cavicchi L; Genovese S; Bertelli D; Benvenuti S; Curini M; Bertaccini A; Bellardi MG
J Agric Food Chem; 2011 Oct; 59(19):10425-34. PubMed ID: 21830789
[TBL] [Abstract][Full Text] [Related]
20. Predicting quantitative phytochemical markers in single Echinacea plants or clones from their DNA fingerprints.
Baum BR; Mechanda S; Livesey JF; Binns SE; Arnason JT
Phytochemistry; 2001 Mar; 56(6):543-9. PubMed ID: 11281131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
